Study of hyaluronic acid efficacy in complex treatment of gastrointestinal tract. As a radiologist, patients with II and III stage of bloodartroz were divided into two main groups (50 patients) and control group (26 patients). The hyaluronic acid preparation was used as a part of the complex treatment as a major group. The ostenol preparation was 2 ml with a 7-day break 3 times in every patient.
Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford) 2014;53(5):93747.
Hunter DJ, Neogi T, Hochberg MC. Quality of osteoarthritis management and the need for reform in the US. Arthritis Care Res (Hoboken) 2011;63(1):31–8.
Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008;59(9):1207–13. [PMC free article]
Murphy LB, Helmick CG, Schwartz TA, Renner JB, Tudor G, Koch GG, Dragomir AD, Kalsbeek WD, Luta G, Jordan JM. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage. 2010;18(11):1372–9. [PMC free article]